# US 2026/0256739 A1 · Therapeutic effect of molecules derived from probiotic milk-based fermentation microbial consortium ("kefir") on wounds healing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0256739 A1
- Document ID: US20260256739A1
- Status: Published application
- Kind: A1
- Application number: 18/997,179
- Filed: 2023-07-31
- Published: 2026-09-03
- Earliest claimed: 2022-07-31
- Assignees: B.G. Negev Technologies and Applications Ltd., At Ben-Gurion University
- Applicants: B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University
- Inventors: Raz JELINEK; Orit MALKA
- Web page: https://patentgrep.com/patent/US20260256739A1

## CPC

- A61K 31/404: Indoles, e.g. pindolol
- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 31/137: Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone}
- A61K 31/192: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid {(cannabinoids A61K31/658)}
- A61K 31/222: with compounds having aromatic groups, e.g. dipivefrine, ibopamine
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 31/02: Local antiseptics
- A61P 17/10: Anti-acne agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention is directed to a pharmaceutical topical composition comprising a Tryptophol derivative and a 4-Ethyl-Phenol derivative. Further provided are methods for using the composition.

## Claims

### Claim 1

A method of treating skin pathologies comprising administering a pharmaceutical topical composition comprising a Tryptophol derivative and a 4-Ethyl-Phenol derivative to a subject in need thereof.

### Claim 2 (depends on 1)

The method according to claim 1, wherein said Tryptophol derivative and a 4-Ethyl-Phenol derivative are in a ratio of 10:1-1:10 w/w ratio.

### Claim 3 (depends on 2)

The method according to claim 2, wherein said Tryptophol derivative and a 4-Ethyl-Phenol derivative are in a ratio of 2:1-1:2 w/w ratio.

### Claim 4 (depends on 1)

The method according to claim 1, wherein said Tryptophol derivative is Tryptophol acetate.

### Claim 5 (depends on 1)

The method according to claim 1, wherein said 4-Ethyl-Phenol derivative is selected from the group consisting of: Tyrosol acetate, dopamine HCL, and caffeic acid.

### Claim 6 (depends on 1)

The method according to claim 1, wherein said skin pathology comprises wounds, burns, burns after radiation in cancer patients, surgical wounds, wounds contaminated with bacteria, wounds contaminated with parasites, diabetic wounds, fusion of skin grafts, acne, eczema rashes, fissures, atopic dermatitis, allergy rashes, gout, joint pains, sprains, impetigo, leishmania, hemorrhoid, pruritus as a result of irritated skin, subcutaneous hemorrhages as a result of injuries or any combination thereof.

### Claim 7 (depends on 1)

The method according to claim 1, wherein said skin pathology is in the scalp, back, hands, legs, face, front upper body area, backside, rectum, vagina, or any combination thereof.

### Claim 8 (depends on 1)

The method according to claim 1, wherein said skin pathology comprises fissures.

### Claim 9 (depends on 4, 5)

The method according to claim 4 and 5, comprising 1250-2500 μM Tryptophol acetate and 1250-2500 μM Tyrosol acetate.

### Claim 10 (depends on 1)

The method according to claim 1, wherein said composition is in the form of a solution, an ointment, a cream, a gel, a paste, a powder, a suspension, a lotion, a foam, a mousse, an aerosol, a spray, a microsphere, a microemulsion, a nanoemulsion, a nanosuspension, a dermal stick, a roll-on, a pump, a bandage, a patch, or a tape.

### Claim 11 (depends on 10)

The method according to claim 10, wherein said composition is in the form of an ointment.

### Claim 12 (depends on 10)

The method according to claim 10, wherein said composition is in the form of a cream.

### Claim 13 (depends on 1)

The method according to claim 1, further comprising an active pharmaceutical ingredient.

### Claim 14 (depends on 13)

The method according to claim 13, wherein said active pharmaceutical ingredient is a microorganism mixture.

### Claim 15 (depends on 13)

The method according to claim 13, wherein said active pharmaceutical ingredient comprises an anti-inflammatory agent, an anti-microbial agent, an anti-parasitic agent, an anti-allergy agent or any combination thereof.
